OPA-15406 Foam

OPA-15406 · Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPA-15406 Foam, covering 2025-09-15 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis [Phase 3]